“…Based on this anatomical relationship between FAAH and CB 1 expression, we predicted that endocannabinoids may act as retrograde signaling molecules at synapses in the brain (Egertová et al, 1998;Elphick and Egertová , 2001) and experimental studies on the hippocampus and cerebellar cortex have proved that this hypothesis was correct (Kreitzer and Regehr, 2001a,b;Maejima et al, 2001a,b;Ohno-Shosaku et al, 2001;). Therefore, it seems likely that endocannabinoids may also act as retrograde messengers at synapses in the many regions of the brain that we describe here where "complementary" expression of FAAH and CB 1 occurs, which include the olfactory cortex, amygdala, dentate gyrus, transitional cortex and neocortex.…”